These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Demonstrated efficacy and mechanisms of sensitivity of ONC201: H3K27M-mutant diffuse midline glioma in the spotlight. Arrillaga-Romany I; Miller JJ Neuro Oncol; 2024 Jun; 26(6):991-992. PubMed ID: 38588460 [No Abstract] [Full Text] [Related]
24. H3 K27M-mutant diffuse midline gliomas in different anatomical locations. Wang L; Li Z; Zhang M; Piao Y; Chen L; Liang H; Wei Y; Hu Z; Zhao L; Teng L; Lu D Hum Pathol; 2018 Aug; 78():89-96. PubMed ID: 29727696 [TBL] [Abstract][Full Text] [Related]
25. Atrx loss as a promising screening tool for the identification of diffuse midline glioma subtype, H3K27/MAPKinase co-altered. Tauziède-Espariat A; Castel D; Ajlil Y; Auffret L; Appay R; Mariet C; Hasty L; Métais A; Chrétien F; Grill J; Varlet P Acta Neuropathol Commun; 2024 Jun; 12(1):105. PubMed ID: 38926805 [No Abstract] [Full Text] [Related]
26. Prevalence and clinicopathological features of H3.3 G34-mutant high-grade gliomas: a retrospective study of 411 consecutive glioma cases in a single institution. Yoshimoto K; Hatae R; Sangatsuda Y; Suzuki SO; Hata N; Akagi Y; Kuga D; Hideki M; Yamashita K; Togao O; Hiwatashi A; Iwaki T; Mizoguchi M; Iihara K Brain Tumor Pathol; 2017 Jul; 34(3):103-112. PubMed ID: 28447171 [TBL] [Abstract][Full Text] [Related]
27. High frequency of H3F3A (K27M) mutations characterizes pediatric and adult high-grade gliomas of the spinal cord. Gessi M; Gielen GH; Dreschmann V; Waha A; Pietsch T Acta Neuropathol; 2015 Sep; 130(3):435-7. PubMed ID: 26231952 [No Abstract] [Full Text] [Related]
28. Neuroimaging features of diffuse hemispheric glioma, H3 G34-mutant: A case series and systematic review. Kurokawa R; Baba A; Kurokawa M; Pinarbasi ES; Makise N; Ota Y; Kim J; Srinivasan A; Moritani T J Neuroimaging; 2022 Jan; 32(1):17-27. PubMed ID: 34632671 [TBL] [Abstract][Full Text] [Related]
29. Addressing diffuse glioma as a systemic brain disease with single-cell analysis. Sahm F; Capper D; Jeibmann A; Habel A; Paulus W; Troost D; von Deimling A Arch Neurol; 2012 Apr; 69(4):523-6. PubMed ID: 22158715 [TBL] [Abstract][Full Text] [Related]
30. Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations. Solomon DA; Wood MD; Tihan T; Bollen AW; Gupta N; Phillips JJ; Perry A Brain Pathol; 2016 Sep; 26(5):569-80. PubMed ID: 26517431 [TBL] [Abstract][Full Text] [Related]
31. Recurrent non-canonical histone H3 mutations in spinal cord diffuse gliomas. Sloan EA; Cooney T; Oberheim Bush NA; Buerki R; Taylor J; Clarke JL; Torkildson J; Kline C; Reddy A; Mueller S; Banerjee A; Butowski N; Chang S; Mummaneni PV; Chou D; Tan L; Theodosopoulos P; McDermott M; Berger M; Raffel C; Gupta N; Sun PP; Li Y; Shah V; Cha S; Braunstein S; Raleigh DR; Samuel D; Scharnhorst D; Fata C; Guo H; Moes G; Kim JYH; Koschmann C; Van Ziffle J; Onodera C; Devine P; Grenert JP; Lee JC; Pekmezci M; Phillips JJ; Tihan T; Bollen AW; Perry A; Solomon DA Acta Neuropathol; 2019 Nov; 138(5):877-881. PubMed ID: 31515627 [No Abstract] [Full Text] [Related]
32. Imaging Correlates of Adult Glioma Genotypes. Smits M; van den Bent MJ Radiology; 2017 Aug; 284(2):316-331. PubMed ID: 28723281 [TBL] [Abstract][Full Text] [Related]
34. Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign. Lee MK; Park JE; Jo Y; Park SY; Kim SJ; Kim HS Eur Radiol; 2020 Feb; 30(2):844-854. PubMed ID: 31446467 [TBL] [Abstract][Full Text] [Related]
35. Characterization of Diffuse Gliomas With Histone H3-G34 Mutation by MRI and Dynamic 18F-FET PET. Vettermann FJ; Felsberg J; Reifenberger G; Hasselblatt M; Forbrig R; Berding G; la Fougère C; Galldiks N; Schittenhelm J; Weis J; Albert NL; Schüller U Clin Nucl Med; 2018 Dec; 43(12):895-898. PubMed ID: 30358620 [TBL] [Abstract][Full Text] [Related]
36. The pontine diffuse midline glioma, EGFR-subtype with ependymal features: Yet another face of diffuse midline glioma, H3K27-altered. Tauziède-Espariat A; Métais A; Mariet C; Castel D; Grill J; Saffroy R; Hasty L; Dangouloff-Ros V; Boddaert N; Benichi S; Chrétien F; Varlet P Brain Pathol; 2024 Jan; 34(1):e13181. PubMed ID: 37331375 [TBL] [Abstract][Full Text] [Related]
37. Malignant gliomas with H3F3A G34R mutation or MYCN amplification in pediatric patients with Li Fraumeni syndrome. Schoof M; Kordes U; Volk AE; Al-Kershi S; Kresbach C; Schüller U Acta Neuropathol; 2021 Sep; 142(3):591-593. PubMed ID: 34264394 [No Abstract] [Full Text] [Related]
38. Noninvasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma. Yu J; Shi Z; Lian Y; Li Z; Liu T; Gao Y; Wang Y; Chen L; Mao Y Eur Radiol; 2017 Aug; 27(8):3509-3522. PubMed ID: 28004160 [TBL] [Abstract][Full Text] [Related]
39. A rare presentation of a spinal diffuse midline glioma in a child: a case report. Isfaoun Z; Laasri K; Jidal M; Cherradi N; Melhaoui A; Chat L; Haddad SE; Kababri ME; Khorassani ME; Kili A; Ansari NE; Hessissen L Pan Afr Med J; 2023; 44():183. PubMed ID: 37484594 [TBL] [Abstract][Full Text] [Related]
40. [Diffuse midline gliomas with H3K27 alteration in children: a clinicopathological analysis of forty-one cases]. Li J; Ma YY; Feng J; Zhao D; Ding F; Tian L; Chen R; Zhao R Zhonghua Bing Li Xue Za Zhi; 2022 Apr; 51(4):319-325. PubMed ID: 35359043 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]